74 filings
Page 3 of 4
8-K
hqmemkqc84evueqj6k4
14 Mar 22
Other Events
8:37am
8-K
g7ja wiy17ay0n1
1 Mar 22
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Pipeline and Business Progress
4:11pm
8-K
k3atjj6s7oqxw
9 Feb 22
Other Events
4:10pm
8-K
sfhg ujnp0
25 Jan 22
Departure of Directors or Certain Officers
8:01am
8-K
z3bez3dm 03is6ajwbp
8 Nov 21
Phathom Pharmaceuticals Reports Third Quarter 2021 Results and Provides Key Clinical, Regulatory, and Business Updates
8:06am
8-K
vp6z4
18 Oct 21
Results of Operations and Financial Condition
7:06am
8-K
qpe3b
27 Sep 21
Other Events
8:08am
8-K
zgq1oir3w1mof
20 Sep 21
Entry into a Material Definitive Agreement
8:06am
8-K
dbrtcsil
8 Sep 21
Other Events
8:05am
8-K
hrzunt7
10 Aug 21
Phathom Pharmaceuticals Reports Second Quarter 2021 Results and Provides Update Regarding Key Clinical and Regulatory Milestones
8:05am
8-K
f0t4o
5 Aug 21
Other Events
7:35am
8-K
iswk6
8 Jul 21
Entry into a Material Definitive Agreement
4:01pm
8-K
0sc x3m8prcltu
4 Jun 21
Departure of Directors or Certain Officers
4:05pm
8-K
u1zk9
25 May 21
Departure of Directors or Certain Officers
4:15pm
8-K
hepbhuivungy xe5t
11 May 21
Phathom Pharmaceuticals Reports First Quarter 2021 Results and Provides Recent Business Updates
8:06am
8-K
5ix1nfw 96b6
29 Apr 21
Other Events
4:18pm
8-K
gbwjruaoswhv24
30 Mar 21
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2020
12:00am
8-K
z8c97xujvy
31 Dec 20
Entry into a Material Definitive Agreement
8:30am
8-K
5go00i
17 Dec 20
Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock
4:26pm
8-K
d7vdqk3a588pj63udkf5
14 Dec 20
Other Events
8:53am